{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:46Z","timestamp":1786980346635,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T00:00:00Z","timestamp":1390003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00592-014-0555-5","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T02:23:42Z","timestamp":1389925422000},"page":"567-575","source":"Crossref","is-referenced-by-count":30,"title":["Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes"],"prefix":"10.1007","volume":"51","author":[{"given":"Salvatore","family":"Calanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Scicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Krag","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata Maria","family":"Rabuazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,18]]},"reference":[{"issue":"Suppl 1","key":"555_CR1","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1):S67\u2013S74. doi: 10.2337\/dc13-S067","journal-title":"Diabetes Care"},{"key":"555_CR2","volume-title":"National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta"},{"key":"555_CR3","volume-title":"National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007","author":"Centers for Disease Control and Prevention","year":"2008","unstructured":"Centers for Disease Control and Prevention (2008) National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta"},{"key":"555_CR4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1525-1497.2004.40178.x","volume":"19","author":"D Edelman","year":"2004","unstructured":"Edelman D, Olsen MK, Dudley TK et al (2004) Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 19:1175\u20131180. doi: 10.1111\/j.1525-1497.2004.40178.x","journal-title":"J Gen Intern Med"},{"key":"555_CR5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","volume":"57","author":"E Muscelli","year":"2008","unstructured":"Muscelli E, Mari A, Casolaro A et al (2008) Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 57:1340\u20131348. doi: 10.2337\/db07-1315","journal-title":"Diabetes"},{"key":"555_CR6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00125-008-0951-x","volume":"51","author":"K Faerch","year":"2008","unstructured":"Faerch K, Vaag A, Holst JJ et al (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853\u2013861. doi: 10.1007\/s00125-008-0951-x","journal-title":"Diabetologia"},{"key":"555_CR7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7150\/ijms.4128","volume":"9","author":"F Zhang","year":"2012","unstructured":"Zhang F, Tang X, Cao H et al (2012) Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance. Int J Med Sci 9:574\u2013581. doi: 10.7150\/ijms.4128","journal-title":"Int J Med Sci"},{"key":"555_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-003-1190-9","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3\u201319. doi: 10.1007\/s00125-002-1009-0","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"555_CR9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1463-1326.2011.01449.x","volume":"13","author":"D D\u2019Alessio","year":"2011","unstructured":"D\u2019Alessio D (2011) The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes Metab 13(Suppl 1):126\u2013132. doi: 10.1111\/j.1463-1326.2011.01449.x","journal-title":"Diabetes Obes Metab"},{"key":"555_CR10","author":"S Calanna","year":"2013","unstructured":"Calanna S, Christensen M, Holst JJ et al (2013) Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia. doi: 10.1007\/s00125-013-2841-0","journal-title":"Diabetologia"},{"key":"555_CR11","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/dc13-0465","volume":"36","author":"S Calanna","year":"2013","unstructured":"Calanna S, Christensen M, Holst JJ et al (2013) Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies. Diabetes Care 36:3346\u20133352. doi: 10.2337\/dc13-0465","journal-title":"Diabetes Care"},{"key":"555_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jcem-63-2-492","volume":"63","author":"MA Nauck","year":"1986","unstructured":"Nauck MA, Homberger E, Siegel EG et al (1986) Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492\u2013498","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR13","doi-asserted-by":"crossref","first-page":"E1144","DOI":"10.1152\/ajpendo.00571.2005","volume":"291","author":"E Muscelli","year":"2006","unstructured":"Muscelli E, Mari A, Natali A et al (2006) Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 291:E1144\u2013E1150. doi: 10.1152\/ajpendo.00571.2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"555_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403. doi: 10.1056\/NEJMoa012512","journal-title":"N Engl J Med"},{"key":"555_CR15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343\u20131350. doi: 10.1056\/NEJM200105033441801","journal-title":"N Engl J Med"},{"key":"555_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383\u2013393. doi: 10.1056\/NEJMoa021778","journal-title":"N Engl J Med"},{"key":"555_CR17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1515\/CCLM.2007.246","volume":"45","author":"A Mosca","year":"2007","unstructured":"Mosca A, Goodall I, Hoshino T et al (2007) Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 45:1077\u20131080. doi: 10.1515\/CCLM.2007.246","journal-title":"Clin Chem Lab Med"},{"key":"555_CR18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/oby.20017","volume":"21","author":"S Calanna","year":"2013","unstructured":"Calanna S, Piro S, Di Pino A et al (2013) Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. Obesity (Silver Spring) 21:320\u2013325. doi: 10.1002\/oby.20017","journal-title":"Obesity (Silver Spring)"},{"key":"555_CR19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1530\/EJE-11-0765","volume":"166","author":"S Calanna","year":"2012","unstructured":"Calanna S, Urbano F, Piro S et al (2012) Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome. Eur J Endocrinol 166:917\u2013922. doi: 10.1530\/EJE-11-0765","journal-title":"Eur J Endocrinol"},{"key":"555_CR20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"555_CR21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/diabetes.52.2.380","volume":"52","author":"LL Kjems","year":"2003","unstructured":"Kjems LL, Holst JJ, V\u00f8lund A, Madsbad S (2003) The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380\u2013386","journal-title":"Diabetes"},{"key":"555_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.diabres.2005.10.005","volume":"72","author":"A Tura","year":"2006","unstructured":"Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72:298\u2013301. doi: 10.1016\/j.diabres.2005.10.005","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 3","key":"555_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","volume":"32","author":"RN Bergman","year":"2002","unstructured":"Bergman RN, Finegood DT, Kahn SE (2002) The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32(Suppl 3):35\u201345","journal-title":"Eur J Clin Invest"},{"key":"555_CR24","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s001250100003","volume":"44","author":"B Ahr\u00e9n","year":"2001","unstructured":"Ahr\u00e9n B, Larsson H (2001) Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations. Diabetologia 44:1998\u20132003. doi: 10.1007\/s001250100003","journal-title":"Diabetologia"},{"key":"555_CR25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"M Nauck","year":"1986","unstructured":"Nauck M, St\u00f6ckmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46\u201352","journal-title":"Diabetologia"},{"key":"555_CR26","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-013-2902-4","volume":"56","author":"DH Morris","year":"2013","unstructured":"Morris DH, Khunti K, Achana F et al (2013) Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489\u20131493. doi: 10.1007\/s00125-013-2902-4","journal-title":"Diabetologia"},{"key":"555_CR27","first-page":"197","volume":"30","author":"MJ Gillett","year":"2009","unstructured":"Gillett MJ (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009, 32(7), pp. 1327\u20131334. Clin Biochem Rev 30:197\u2013200","journal-title":"Clin Biochem Rev"},{"key":"555_CR28","author":"BHR Wolffenbuttel","year":"2013","unstructured":"Wolffenbuttel BHR, Herman WH, Gross JL et al (2013) Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care. doi: 10.2337\/dc12-2711","journal-title":"Diabetes Care"},{"key":"555_CR29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/joim.12010","volume":"273","author":"H Jansen","year":"2013","unstructured":"Jansen H, Stolk RP, Nolte IM et al (2013) Determinants of HbA1c in nondiabetic Dutch adults: genetic loci and clinical and lifestyle parameters, and their interactions in the lifelines cohort study. J Intern Med 273:283\u2013293. doi: 10.1111\/joim.12010","journal-title":"J Intern Med"},{"key":"555_CR30","first-page":"4053","volume":"85","author":"P Shah","year":"2000","unstructured":"Shah P, Vella A, Basu A et al (2000) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85:4053\u20134059","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","volume":"50","author":"FK Knop","year":"2007","unstructured":"Knop FK, Vilsb\u00f8ll T, Madsbad S et al (2007) Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia 50:797\u2013805. doi: 10.1007\/s00125-006-0566-z","journal-title":"Diabetologia"},{"key":"555_CR32","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2337\/db07-0100","volume":"56","author":"FK Knop","year":"2007","unstructured":"Knop FK, Vilsb\u00f8ll T, H\u00f8jberg PV et al (2007) Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56:1951\u20131959. doi: 10.2337\/db07-0100","journal-title":"Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-014-0555-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0555-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:00:34Z","timestamp":1559124034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-014-0555-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,18]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1007\/s00592-014-0555-5","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,18]]}}}